ISPOR’s 2024 HEOR Awards

Who won the ISPOR’s 2024 HEOR awards? The list is below.

Avedis Donabedian Lifetime Achievement Award: C. Daniel Mullins, PhD; Professor of Practice, Sciences, and Health Outcomes Research and Executive Director of The PATIENTS Program; University of Maryland School of Pharmacy; Baltimore, MD, USAMarilyn Dix Smith Leadership Award: Deborah Marshall, PhD; Professor and Svare Chair in Health Economics, Value, and Impact; University of Calgary; Calgary, Alberta, CA Bernie O’Brien New Investigator Award: Natalia Kunst, PhD; Senior Research Fellow (Associate Professor); Centre for Health Economics; University of York; York, England, UKLow- and Middle Income Country (LMIC) Health Economics and Outcomes Research Excellence Award: Nelson Rafael Alvis-Guzman, MD, PhD; Professor, Universidad of Cartagena; Cartagena, ColombiaAward for Excellence in Health Economics and Outcomes Research Methodology: William Padula, PhD; Assistant Professor, University of Southern California; Los Angeles, CA, USA for the article, “Predicting pressure injury risk in hospitalised patients using machine learning with electronic health records: a US multilevel cohort study;” [BMJ Open. 2024;14(4): e082540.]Award for Excellence in Health Economics and Outcomes Research Application: Inmaculada Hernandez, PhD; Professor, University of California San Diego; San Diego, CA, USA for the article, ”Changes In net prices and spending for pharmaceuticals after the introduction of new therapeutic competition.” [Health Aff (Millwood). 2023;42(8):1062-1070.]Value in Health Paper of the Year Award: Aurélie A. Meunier, MSc; Director, Modelling, HEOR, Putnam; London, England, UK for the article, “Distributional cost-effectiveness analysis of health technologies: data requirements and challenges.” [Value Health. 2023;26(1):60-63.]Value in Health Regional Issues Excellent Article Award: Carleigh B. Krubiner, PhD; Bioethics Lead, Wellcome; London, England, UK for the article, “The value of explicit, deliberative, and context-specified ethics analysis for health technology assessment: evidence from a novel approach piloted in South Africa.” [Value Health Reg Issues. 2023;34:23-30]